The recent declaration by the World Health Organization (WHO) of mpox outbreaks in Congo and other African countries as a global health emergency has raised concerns about the potential for another pandemic. In this opinion piece, we explore the likelihood of mpox becoming a global threat and compare it to previous pandemics.
Understanding Mpox
Mpox, also known as monkeypox, differs significantly from airborne viruses like swine flu and COVID-19. It primarily spreads through close skin-to-skin contact with infected individuals or contaminated materials, such as clothing or bedsheets. Visible skin lesions associated with mpox may discourage close contact, reducing transmission risk.
Unlikely to Trigger a Pandemic
Unlike rapidly spreading airborne viruses, mpox spreads slowly. While Europe’s Centre for Disease Prevention and Control warns of more imported cases from Africa, the chances of local outbreaks in Europe remain very low. Scientists believe the risk to the general population in countries without ongoing mpox outbreaks is minimal.
Key Differences from COVID-19
Mpox’s slow transmission contrasts sharply with the exponential growth of COVID-19 cases. The coronavirus surged from hundreds to thousands within weeks, whereas mpox cases increase at a much slower rate. Additionally, mpox lesions make close contact less likely, further limiting its spread.
While mpox poses a serious public health concern, the likelihood of it triggering a global pandemic appears remote. Vigilance, international cooperation, and adherence to hygiene practices remain crucial in containing this outbreak and preventing further spread.